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 Summary 
The present report documents the results of a research project, which has been initiated following a 
request of the Ministry of Housing, Spatial Planning, and the Environment (VROM), to assess the 
food and feed safety aspects of cisgenic plants and derived products. The focus will thereby be on the 
application of cisgenesis in crop plants. The research project consisted of the following parts: 
1) a desk study that was carried out by experts of RIKILT; 
2) discussions with national experts as represented in the steering committee of the project and 
international experts on the basis of draft reports;  
3) an international web-seminar with other invited experts in the area of i) plant breeding and ii) 
food and feed safety of genetically modified organisms, with the purpose of further exchanging 
scientific views on identified food and feed safety aspects of cisgenic plant varieties. 
 
This report presents the results of the discussions that identified food and feed safety aspects of 
cisgenic plant varieties in comparison to conventional varieties on the one hand and transgenic plant 
varieties on the other hand. It was concluded that on the basis of the general characteristics of cisgenic 
plant varieties, there is, from a food and feed safety perspective, no scientific basis for a general 
reduction of requirements for cisgenic crop plant varieties. At the same time there was large consensus 
that an optimal food and feed safety assessment for all new plant varieties should be based on the 
specific characteristics of the individual novel plant variety (product based), rather than on the 
categorisation of the new plant varieties and their derived products on the basis of (one of) the 
technologies used to obtain the new plant variety (process based). 
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 1 Introduction 
The Dutch Ministry of Housing, Spatial Planning, and the Environment (VROM) has requested 
RIKILT to carry out a research project on the food and feed safety of cisgenic crop varieties. 
Cisgenesis is a form of genetic modification for which only sequences of the host organism or 
‘related’ organisms are introduced. Cisgenesis is currently also one of the techniques being considered 
by a working group of the European Commission with regard to its status under the EU legislation on 
genetically modified organisms (GMOs). The Dutch Ministry of VROM is also actively involved in 
this European discussion and also liaises on this topic with the Ministry of Agriculture, Nature, and 
Food Quality, and with the Ministry of Public Health, Welfare, and Sports. The project was started in 
August 2009. 
 
 
 
Figure 1. This project aims to compare aspects of food and feed safety of transgenic vs cisgenic vs conventional 
plant varieties. 
The aim of the project was to identify and conclude about food and feed safety aspects of cisgenic 
genetically modified (GM) plant varieties in comparison to conventional varieties on the one hand and 
transgenic GM plant varieties on the other hand. 
 
In this report the reader will find the following items: 
• a description of background of the project; 
• a description of the organisation of the study; 
• a discussion part on food and feed safety aspects of the definition of cisgenic plant varieties; 
• a concise overview of cisgenesis-like developments in the scientific literature; 
• a discussion part on aspects of food and feed safety of cisgenic plant varieties; 
• a final discussion on aspects of food and feed safety of cisgenic plant varieties;  
• a number of overall conclusions. 
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 2 Background 
2.1 Background information, general 
Since the first large-scale market introduction of genetically modified crops in 1996, the worldwide 
area planted with these crops has continuously grown, reaching 134 million hectares in 2009 (James, 
2009). The majority of these crops are cultivated outside the European Union (EU), whilst harvested 
crops and derived products are imported into the EU after their approval. Examples of such genetically 
modified crops are herbicide-tolerant soybean and insect-resistant maize. These genetically modified 
crops are transgenic, which means that they have been created with different genetic elements from the 
same or other species. 
Various genetically modified crops that are now in preparation (almost) exclusively contain DNA 
sequences that naturally occur within the same crop species, the so called ‘cisgenic’ crops. In the 
scientific literature no detailed information is yet available on novel cisgenic plant varieties. 
Cisgenesis in apple was only briefly described by Gessler et al. (2009) who transformed the HcrVf2 
gene from Malus floribunda into commercial cultivars like Gala and Elstar. The authors make use of 
the selectable marker nptII, but remove this marker in a second phase. Some stakeholders assume that 
this type of modification can alleviate public concerns with regard to genetic modification because, 
unlike for transgenic GM crops, no boundaries among species are crossed. It is also assumed that this 
technique does not differ fundamentally from conventional crop breeding, through which, at least in 
theory, the same results can be obtained. Various scientific and corporate institutions in the 
Netherlands are working on the development of cisgenic crops, including a Phytophthora-resistant 
potato. The topic of cisgenesis has captured public attention in a number of ways, including a report 
by the Netherlands Commission on Genetic Modification (COGEM) on new genetic techniques for 
crop improvement (COGEM, 2006), societal gatherings, a political discussion within the Dutch 
Parliament, and a request by the Senate to verify within an EU context if exempting cisgenesis from 
the current EU GMO legislation (EU Regulation 1829/2003) or reduced requirements for the safety 
assessment of cisgenic GM crops is possible. 
2.2 Background information, safety assessment 
Before genetically modified organisms (GMOs) can be released on the market, they will have to be 
approved, both for their introduction in the environment and for their application as food and feed 
[Directive 2001/18/EC and/or Regulation (EC) 1829/2003, respectively]. Cisgenic GM crops fall 
under the definition of a GMO according to EU legislation and therefore would have to be evaluated 
for their environmental and food/feed safety. The applicant for an authorisation is requested to provide 
an extensive dossier containing data and information on the donor and host organisms and the genetic 
modification to demonstrate that the GMO in question does not have adverse effects on human health, 
animal health, and the environment. The assessment of food and feed safety is based on the 
internationally harmonized comparative approach, which has been enshrined in Guidance Documents 
published by the Codex Alimentarius Commission and the European Food Safety Authority (EFSA). 
The first step is the comparative analysis of molecular, agronomic and morphological characteristics 
as well as the chemical composition of the GMO and its conventional counterpart with a history of 
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 safe food/feed use. Based on the outcome of this comparison it can be decided which further tests will 
be needed to assess the food/feed safety. The potential toxicity and allergenicity of newly expressed 
proteins, consistent unintended effects and horizontal gene transfer, as well as nutritional value of the 
GMO and/or the introduced elements are subject of further investigations. 
 
Recently, two reports were published by COGEM (COGEM, 2006) and Plant Breeding, Wageningen 
UR (Jacobsen and Schaart, 2009), respectively, that considered the possible safety issues surrounding 
T-DNA borders. The underlying thought was that, during cisgenesis by means of T-DNA integration 
with the aid of Agrobacterium tumefaciens, these T-DNA borders would be the sole “foreign” 
elements that are introduced into the host’s DNA. The potential formation of an epitope (recognized 
by IgE anti-sera of allergic patients) by the theoretical amino acid sequences corresponding to the T-
DNA was thus considered as the potential safety issue. Another issue of integrated T-DNA borders is, 
although considered to be unlikely, the potential formation of chimerical novel open reading frames. 
Moreover, the natural occurrence of sequences similar to T-DNA in plant DNA was confirmed, also 
with the aid of bioinformatics (Jacobsen and Schaart, 2009). Reference was also made to a previous 
COGEM opinion in which COGEM considered it highly unlikely that integration of T-DNA borders 
would cause environmental risks. Since no conclusions about the food/feed safety have been drawn in 
these previous reports, this current report will complete the risk assessment. 
 
RIKILT has provided comments to the above mentioned risk evaluation of T-DNA borders as the 
principle aspect of the safety assessment of cisgenic GM plant varieties. Another point of interest was, 
for example, the safety aspects related to the definition of cisgenesis as used by the authors of the 
report on T-DNA borders, which would also allow for the use of sequences from wild relatives, the 
latter without having a history of safe use. Also, the safety assessment of cisgenic crops according to 
the approach applied to GMOs will not be limited to the T-DNA sequences but also considers, 
amongst others, the possible fusion products on the basis of plant-endogenous sequences and the 
cisgenic construct. The prior history of exposure to the newly expressed proteins in cisgenic GM 
plants could, on the other hand, possibly give rise to a less profound set of data requirements for the 
safety assessment. In summary, RIKILT concluded that no categorical statement can be made with 
regard to the possibly diminished safety concerns about cisgenesis (Kleter and Kok, 2009). 
 
The present project has mapped, in more detail, the landscape of potential food/feed safety issues 
surrounding cisgenesis, with a view on possible relaxation of requirements with respect to safety data 
that need to be supplied by the applicant before market approval as is stipulated in EU Regulation 
1829/2003. This has been done by comparing the food and feed safety aspects of cisgenic plant 
varieties with, on the one hand, conventionally bred plant varieties without the use of recombinant-
DNA techniques and, on the other hand, transgenic GM plant varieties as are currently subject to EU 
Regulation 1829/2003. 
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 3 Approach 
3.1 Organisation of the study 
This study comprises three different parts: 
1) A desk study into the available knowledge on cisgenic crops, among others with regard to the 
types of modifications that have been introduced and the molecular changes that they cause in the 
DNA of the host organism, as well as the associated change(s) at the level of expression (mRNA, 
protein, metabolites). These changes will be considered from the perspective of what is already 
known about the changes that can occur during conventional breeding and transgenic 
modifications of crops. The desk research has also considered if there is a history of safe use of 
the elements introduced through cisgenesis (including the T-DNA borders), and also what safety 
aspects should be considered (similar to what is done during the comparative safety assessment of 
GMOs).  
2) Extensive discussions with national experts, members of the steering committee and with 
international experts in the area of plant breeding and the food and feed safety assessment of 
complex food products during three subsequent meetings. Draft reports as prepared by RIKILT 
were the basis for these discussions. 
3) An international web-seminar that was organised by RIKILT at Wageningen UR with >200 
invited experts worldwide in the area of i) plant breeding and ii) food and feed safety of 
genetically modified organisms. The aim of the web-seminar was to further exchange scientific 
views on identified food and feed safety aspects of cisgenic plant varieties. Approximately 50 
experts signed in for participation, of which 20 provided (interactive) feedback to the web-
seminar presentations.  
 
This project report has been compiled on the basis of the combined results of all parts of the project. 
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 4 Cisgenesis - definitions  
4.1 Definition according to the EU Working Group on Novel Techniques 
It was decided during the first project meeting that this report would use the definitions of cisgenesis 
and transgenesis, as defined in the draft document by the EU Working Group on Novel Techniques 
(WGNT), in this report referred to as the WGNT-definitions: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Definition and brief description of cisgenesis and intragenesis based on the current 
scientific knowledge and current scientific literature 
Cisgenesis is a genetic modification of a recipient species with a natural gene from a crossable - 
sexually compatible - organism (same species or a closely related species). Such a gene includes 
its introns and is flanked by a native promoter and terminator in the normal sense orientation.  
 
Intragenesis is different from cisgenesis. This is the integration of an intragene. An intragene is 
commonly a hybrid gene and intragenesis involves the insertion of a reorganized, full or partial 
coding part of a natural gene frequently combined with another promoter and/or terminator from 
a gene of the same species or a crossable species. 
 
Cisgenic plants can harbour one or more cisgenes, but they do not contain any transgenes. To 
produce cisgenic plants, any suitable technique used for production of transgenic organisms may 
be used. Genes must be isolated, cloned and transformed back into a recipient. 
 
A comparison based on differences and similarities between established WGNT-definitions like 
transgenesis or traditional breeding can be made to place the concept of cisgenesis into perspective: 
Cisgenesis vs. transgenesis: 
Both make use of illegitimate recombination to insert a desired DNA sequence into a genome, 
resulting in the rudimentary deposit of at least one T-DNA border of Agrobacterium and possible 
effects by the recombinational insertion. 
Cisgenesis vs. traditional breeding: 
In both cases the resulting plants contain DNA sequences that are within the species-range of the 
recipient genome. Therefore, no new DNA, not belonging to the species’ natural gene pool, is being 
introduced, but insertional mutagenesis may occur and the formation of new fusion proteins can not be 
excluded. Techniques that belong to ‘traditional breeding methods’ also comprise mutation breeding 
and translocation breeding, potentially inducing the same illegitimate recombinations as with 
cisgenesis (and transgenesis). Interspecific crosses would also not be allowed or at least be 
questionable within the concept of cisgenics. 
An advantage of cisgenesis over traditional breeding is the lack of linkage drag (the unwanted genetic 
material that is introduced in the progeny besides the desired trait) that would have been introduced 
into the progeny when a normal crossing would occur. In a normal situation, a crossing would have to 
be made, followed by recurring back crossings to reduce the linkage drag in the selected germ line 
while maintaining the desired trait. As this linkage drag may also entail genetic sequences that may 
have consequences for the food and feed safety of the resulting product, for instance in the case of a 
conventional cross with a wild relative that has never been used for human consumption, it is clear 
that, in terms of food and feed safety, in this respect cisgenesis may have advantages over 
conventional breeding. 
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 4.2 ‘Cisgenic-like’ approaches in scientific literature - definitions 
In literature, different terms are used to describe the use of self-genes in transformation events. These 
are autotransgenesis (Beardmore, 1997; Nam et al., 2008), intragenesis (Rommens, 2004; Rommens, 
2007; Russell and Sparrow, 2008), cisgenesis (Schouten et al., 2006; Schouten et al., 2006a) and 
variations thereof. 
Figure 2 is published by Hanley (2009) and depicts three different types of plant genes in different 
shades of green. Hanley regards cisgenesis as the use of a construct in which the gene is derived from 
the same species and is flanked with the original flanking regulatory sequences. Intragenics allows 
shuffling of genes and regulatory sequences. Rommens’ definition of cisgenesis allows that the gene 
may be introduced by Agrobacterium, while Connor limits the definition to the use of a plant-derived 
intragenic vector system. Last, Hanley presents cisgenics as the generation of a transgenic organism 
were elements of the organism’s own genome are used instead of elements from other genomes 
(Hanley, 2008). 
 
Figure 2: Open reading frame composition of different X-genic principles. Source: (Hanley, 2009) 
It shows that different (interpretations of) definitions for cisgenesis and transgenesis are being used in 
literature. For further reading regarding different aspects of cisgenesis and intragenesis, the reader is 
referred to a selected set of literature (Jochemsen, 2000; Jacobsen and Schouten, 2007; Rommens, 
2007; Rommens et al., 2007; Rommens, 2008; Russell and Sparrow, 2008; Benjamin et al., 2009; 
Strauss et al., 2009). 
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 4.3 Considerations on definition aspects (species, crossability, endogenous 
DNA) 
As can be seen in the former paragraphs, most cisgenesis-related definitions, including the WGNT-
definitions, are broadly formulated and many details remain unspoken, such as: 
• The use of endogenous promoters and terminators vs. novel combinations of genes and regulatory 
elements; 
• Tissue-specific expression vs. redirection of the transcribed gene product to a different organelle 
or plant part; 
• Usage of identical codon usage vs. the possibility to codon-optimise the gene; 
• One single integration of the gene-of-interest vs. possible rearrangements/partial genes due to the 
transformation procedure; 
• When a cisgene per definition originates from the same Species, Genus or Family, what happens 
when the classification of a species is shifted?; 
• At what point should the definition be applied: does it refer to the intended modification or only to 
the modification that has actually taken place in the plant. With other words, if a cisgenic 
construct is transferred to a plant, but rearrangements occur that lead to new genetic combinations 
in the plant, would this still fall under the same definition? 
 
These unclarities would be crucial if specific categories of (cisgenic/intragenic) plant varieties would 
be proposed for diminished data requirements. It is clear that any of these items may, in specific cases, 
have consequences, in terms of food and feed safety, for the resulting plant products.  
 
Also, the species definition is not a rigid one (http://en.wikipedia.org/wiki/Species; Staley (2009)). 
Some participants in the web-seminar stated that it is possible to establish objective criteria for species 
and crossability, but in general it was felt that the inclusion of these aspects in the definition in general 
will lead to ‘grey areas’ where you do not know the actual degree of crossability of the host and 
receptor lines of the cisgenic event. During the web-seminar it was also brought forward that, in 
addition to the exchange of chromosomal DNA, genetic modification may also include the exchange 
with plastid genes (Bock, 2001; Quesada-Vargas et al., 2005; Noutsos et al., 2007; Craig et al., 2008). 
It is not clear whether this would fall under the definitions as mentioned above. 
 
A further aspect refers to the (endogenous) character of T-DNA: Agrobacterium, the bacterium of 
choice for delivering gene constructs into plant cells, is a soil bacterium that thrives on symbiosis with 
(dicotyledonous) plants. It is very likely that redundant T-DNA is present in a large number of plant 
species, due to a symbiotic relation along evolution. The intragenic vector system, aiming to use only 
vectors that consist of DNA that originates from the same crop species or related species to which it 
can be hybridized (Conner et al., 2007), could in theory use these redundant T-DNA sequence motifs 
that might be present in the plant genome. Currently, in scientific publications the P-DNA approach is 
applied in which plant-derived transfer DNA (P-DNA) is used (Rommens, 2004; Rommens et al., 
2004; Conner et al., 2007). Ergo, once the presence of T-DNA borders has been established in the 
genome of a plant species that is to be transformed, or any other sequence used in a gene construct, the 
T-DNA borders may be regarded as ‘self-DNA’. The plants derived by this method should still be 
regarded as intragenic since the (P-DNA) vector is created artificially from reorganised pant-derived 
sequences. 
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 4.4 Conclusions on aspects of definition 
The impossibility to currently define cisgenesis in a ‘watertight’ way will lead to considerable ‘grey 
areas’ the moment that the group of cisgenic plant varieties would, for instance, be exempted from the 
EU Directive 2001/18/EC and therefore also from Regulation 1829/2003, or be treated differently in 
any other way: at that moment it would be crucial to know exactly which novel plant varieties could 
fall under the definition of cisgenesis and which not. This may also have safety consequences, as 
current definitions of cisgenesis may include novel plant varieties that, for instance, express proteins 
that have never been part of the human or animal diet. From a food/feed safety perspective it would 
not be desirable to approve this type of cisgenic plant varieties for the (European) market without any 
pre-market safety assessment of at least the newly expressed proteins, or indeed the new plant product 
as a whole. 
RIKILT Report 2010.001 14 
 5 Aspects of food and feed safety 
5.1 Current regulation of GMOs vs conventionally bred new plant varieties 
There is a discrepancy between the regulation of GM plant varieties and other novel plant varieties 
that have been obtained via conventional breeding. As a result of this, there is a discrepancy between 
the food and feed safety assessment requirements for these two different categories of new plant 
varieties: All GMOs need to be assessed in detail for their food and feed safety, whereas safety 
assessment of other categories of new plant varieties is only required in the case of certain concerns on 
the basis of known alterations in the plant’s physiology.  
 
The basic approach for the food and feed safety assessment of GM plant varieties consists of a 
comparative safety assessment of the novel GM crop with an appropriate comparator (OECD, 1993; 
FAO/WHO, 1996; OECD, 1996; OECD, 1998; Kok and Kuiper, 2003; Konig et al., 2004; EFSA, 
2006). The comparators are crops that are on the market and already have a so-called history-of-safe-
use. In the comparative safety assessment, the GM crop and the comparator(s) are grown under the 
same conditions. They are compared with regard to their molecular, agronomic and phenotypic 
characteristics and their chemical composition with the aim to identify differences between the GM 
crop and the comparable non-GM crop(s) that may be related to the genetic modification. The 
subsequent safety assessment steps will then focus on the differences that have been identified to see 
whether these differences may have any (unintended) toxicological, allergenic and/or nutritional 
consequences. In practice, if differences have been identified, the subsequent steps of the food and 
feed safety assessment procedure will be decided on a case-by-case basis, depending on the nature of 
the identified difference(s). 
 
Basic information that will be part of a dossier for food and feed safety analysis in all GMO cases is: 
 
• data on the molecular characteristics of the GM plant with respect to the inserted DNA elements, 
such as data on all detectable inserts into the plant genome, both complete and partial, and derived 
phenotype. In the European Union, information also needs to be provided on the place of 
insertion, i.e. the organization of the inserted genetic material at the insertion site, as well as 
sequence information on the flanking regions (EFSA, 2006). 
• data on gene expression (intended changes). In specific cases, if this is relevant, this may be 
extended to different developmental stages of the plant (tissue) or to different plant parts. If the 
molecular characterization has identified the possibility of a fusion protein (unintended effect), it 
needs to be shown whether this putative fusion protein is actually expressed in the plant parts that 
will be marketed.  
• data on the genetic stability of the inserted sequence in subsequent generations (i.e. a molecular 
biological characterisation). 
• compositional data of, usually, the GM plant and its appropriate comparator(s) in order to detect 
potential unintended side effects of the genetic modification. The compositional analysis should 
comprise all key nutrients and anti-nutrients, including natural toxins, of the specific crop under 
investigation. To this end the OECD (OECD, 2006) has formulated Consensus Documents for 
many of the major crops describing the crop and the relevant constituents with relation to its food 
and feed safety. In general, this comparative analysis is done in a two-tiered approach. In the first 
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 step the comparison is made between the GM plant and the direct comparator. If significant 
differences are detected, the biological relevance is assessed in the second step, by comparing the 
observed values with data as they are compiled in specific databases, such as the ILSI crop 
composition database (www.cropcomposition.org), or are documented in scientific literature. 
• data on the estimated intake of the GM crop derived foods on the basis of available consumption 
data of the crop in general and, where relevant, for specific consumer groups. 
 
In the final step of the food and feed safety assessment all this information is compiled and assessed 
for its potential toxicological, allergenic and nutritional relevance. Important parts of this overall 
assessment are: 
 
• studies with the newly expressed proteins, usually on the basis of comparisons of the amino acid 
sequence of the new protein with those of known toxins and both in vitro as well as in vivo 
experimental data. If there are new constituents besides proteins, for instance metabolites or higher 
levels of endogenous compounds as shown by the compositional analysis, these will also have to 
be assessed. 
• in specific cases: toxicological studies with the whole GM plant or derived food/feed products. In 
general, this will be a sub-chronic toxicity study with rodents. 
• studies on potential allergenicity of the newly introduced proteins as well as the entire plant 
product. This will be done by an initial amino acid sequence comparisons with known allergens. If 
the plant species contains endogenous allergens (e.g. soybeans) the expression levels in the GM 
and the respective non-GM plant need to be compared. 
• studies on the nutrient composition in the GM plant product(s) versus the comparator(s) in 
combination with the biological efficacy of the individual components and the dietary intake of 
the entire product. In specific cases, where relevant questions can not be answered by the 
nutritional assessment, this may lead to the necessity of a post-marketing monitoring programme 
to obtain further data for the nutritional evaluation of the GM plant and its products. 
 
Since this concise overview reflects the requirements for GMO safety assessment, it clearly shows the 
large difference between data requirements for GMOs versus conventionally bred new plant varieties.  
5.2 Food and feed safety issues of cisgenic vs conventionally bred new plant 
varieties 
Conventionally bred new plant varieties will in general not have to go through a food and feed safety 
assessment procedure. In some cases, i.e. in plant species where it is known that high levels of natural 
toxins may occur, it may be necessary to analyse for these toxic compounds prior to variety 
registration. This is for instance, the case with glycoalkaloids in new potato varieties, but this is the 
exception to the rule, in most cases no specific analyses with relation to food and feed safety will have 
to be performed prior to the marketing of the conventionally bred new plant variety.  
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Figure 3: Schematic overview of the phenomenon of ‘linkage drag’ and the regulatory requirement for food and 
feed safety assessment in the case of cisgenic versus conventional new plant varieties. 
As was observed under 5.1., the discrepancy with current regulatory requirements for the food and 
feed safety assessment of new (cisgenic) GM plant varieties is very large (Figure 3) and in specific 
cases this may result in very different safety requirements for conventionally bred or cisgenic GM 
varieties with basically comparable targeted changes. 
 
In Schouten et al. (2006) it is stated that “The largest advantage of the application of cisgenesis 
compared to conventional breeding in the case of sexually compatible plants, is that the gene of 
interest can be transferred in a ‘clean’ way and the so-called ‘linkage drag’ of deleterious genes 
associated with the desired trait in e.g., a wild relative will not hamper or impede the breeding 
process”. As a consequence Schouten et al. claim that cisgenic plants should be exempt from current 
GMO regulatory requirements (Schouten et al., 2006). In Kok et al. (2008), these claims were 
discussed from a food and feed safety perspective: ”It is not clear, however, how unambiguous the 
definition of cisgenesis is in terms of food safety, as it may not exclude wild relatives that are not part 
of the human diet so far that can only be crossed under laboratory conditions. A number of food safety 
aspects that are the key to novel transgenic varieties, such as the safety assessment of the expressed 
proteins, may indeed be much less relevant for these cisgenic plant varieties, as the genes involved 
were already within the available gene pool when using traditional breeding strategies. If the (distant) 
relative is also being used as a food source, the safety assessment of the newly introduced protein may 
obviously benefit from the knowledge that it is already part of the human diet. The food safety 
assessment should take this into account and be conducted accordingly. On the other hand, the wild 
relative may not form part of the human diet yet, and in that case it would be prudent to assess the 
safety of the newly introduced nucleotide sequences and protein(s). But indeed this can only be 
justified if the same approach would be followed when a novel plant variety that would be the result of 
a traditional cross of the same parent lines, with any (remaining) linkage drag, would also be assessed 
within the regulatory frameworks of the food safety assessment of new plant varieties.” The opinion 
was endorsed by the present project members. 
 
The inclusion of not only genes from the crop plant itself, but also from ‘crossable’ plant varieties, 
indeed opens the possibility to use novel genes from other plant varieties, e.g. wild relatives, that do 
not yet form part of the food chain. This can be regarded as a safety aspect with relation to the 
definition of cisgenesis. From a food and feed safety perspective, these expression products may not 
have a so-called ‘history of safe use’ and therefore will require an in-depth safety analysis in terms of 
toxicity/allergenicity prior to marketing. Also, increased expression of ‘plant-own’ DNA may, in 
specific cases, affect the food and feed safety of new plant varieties, e.g. in the case of inherent toxic 
and/or allergenic proteins. 
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 The approach for the safety assessment of conventional breeding – to consider the crop (and the 
potential change), and assess known natural toxins and/or anti-nutrients, with known hazards – has 
worked well to date for new plant varieties. However, nowadays also so-called conventional breeding 
has techniques at hand that can lead to considerable differences in the plant’s physiology and thus in 
crop composition. In fact it can be argued that some conventional breeding methods like induced 
mutagenesis (Brunner, 1995; Ahloowalia and Maluszynski, 2001) have even a higher probability of 
unexpected genetic changes (Shirley et al., 1992; Mei et al., 1994) than cisgenesis. On the basis of this 
it would be prudent to require some form of safety assessment for all novel plant varieties and not just 
for those now considered to be GM plant varieties. 
 
On the other hand, cisgenic products also have the chance of unintended effects due to insertional 
mutagenesis at or by the insertion site (see also 5.3), as was confirmed by plant breeding experts, and 
thus do not differ from GM plants. At the same time it is clear that strategies for homologous 
recombination and directed mutagenesis become increasingly advanced. With these, in the (near) 
future it may be feasible to precisely direct the genetic modification, thereby overcoming (part of) the 
hazards related to effects caused by the random insertion that are linked to genetic modification, both 
by cisgenesis and transgenesis strategies. 
5.3 Food and feed safety issues of cisgenic vs transgenic plant varieties 
Cisgenic varieties are currently within the scope of Regulation 1829/2003 (GMO Food and Feed) (EC, 
2003a) since the techniques by which they were produced are not excluded from Directive 
2001/18/EC. Therefore, the requirements for the safety assessment for cisgenic and transgenic GM 
plants are the same. These requirements can be divided into two parts: 1) the assessment of the newly 
introduced gene sequences and their (intended) expression products and derived effects and 2) 
potential unintended effects caused by the genetic modification (see 5.1). It can be argued that the 
required studies for the first part of the assessment can be reduced for cisgenic plant varieties where 
the expression products are known for the specific crop plant and are well-characterised, and 
expression levels are within ‘normal’ ranges (to be decided on a case-by-case basis). For the second 
part, the assessment will not only focus on the introduced T-DNA borders, as has been suggested, but 
also on the potential fusion proteins derived from the border regions of the introduced sequences and 
the endogenous DNA. Further, the 5’ and 3’ genomic sequences flanking the cisgene insert need to be 
analysed in order to identify whether endogenous genes have been interrupted or its expression level 
have been changed. Considering the large variety of potential cisgenic crop plant products it is not 
feasible to formulate generally applicable guidelines and thus, the assessment needs to be done on a 
case-by-case basis. For this assessment data on the place of insertion as well as on the (biochemical) 
composition of the plant (parts) that will be consumed need to be supplied, comparable to the 
assessment of GM plant varieties. If differences are identified, further safety testing may be required 
for both transgenic and cisgenic plant varieties. 
5.4 Other safety-related considerations 
A specific aspect that has been discussed in this respect is the safety assessment of T-DNA borders: 
the introduction of either cisgenic or transgenic DNA sequences by disarmed soil bacterium 
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 Agrobacterium tumefaciens transformation will likely result in the rudimentary deposit of a so-called 
left border of the T-DNA. The right border is absent in most cases. The size of this left border is 2-24 
base pairs. With respect to safety, it can be argued that this sequence might influence the 
transcription/translation system by either direct translation into a maximum of 8 amino acids, or 
disturb the reading frame, thereby possibly creating an even larger transcript (Jacobsen and Schaart, 
2009). Possible effects can be envisaged due to the presence of this putative peptide (toxicity or 
selective advantage), or its characteristics in case the gene product appears to be allergenic. The sole 
presence of the rudimentary T-DNA border itself is not likely to cause unintended effects in terms of 
toxicity or allergenicity in the cisgenic plant variety due to the limited amount of nucleotides that can 
encode for a maximum of eight amino acids. In fact, as A. tumefaciens is using plants for a symbiotic 
relationship, it is likely that many plant species already contain identical or similar DNA sequences, as 
has been determined for A. rhizogenes (Intrieri and Buiatti, 2001). The frame shifts, however, that 
could have been introduced by the T-DNA left border insertion, and that may lead to new (fusion) 
proteins, can differ from transformant to transformant. The assessment of potentially induced or 
increased levels of allergenicity/toxicity will be part of the overall food and feed safety assessment on 
the basis of the molecular characterisation of the entire genetic modification and not just on the T-
DNA present, and therefore will have to be performed on a case-by-case basis (See section 5.1). 
 
In cisgenesis (as in conventional breeding and transgenesis) the gene expression level of the 
introduced gene might deliberately or by accident be out of the natural range of expression variation 
(i.e. the range found in conventional crop varieties). This might occur even if the regulatory sequences 
from the same plant are used in the case when multiple copies are generated, or due to position effects 
(Filipecki and Malepszy, 2006). Due to position effects or the use of other regulatory elements (if from 
the same species, this would fall under the definition of intragenesis), the level of gene expression 
might be higher than the naturally occurring level of expression (Kim and Grierson, 2005; Kang et al., 
2007; Zheng et al., 2008; Feng et al., 2009). This might have consequences for the safety evaluation. 
Indeed (intended) changes of protein expression, or derived bioactive compounds, in the same plant 
species using cisgenesis would be a relevant part of current food and feed safety evaluation. Bioactive 
compounds today have a positive connotation, but it is known that there are optimal concentration 
ranges in this respect for health benefit, as was pointed out by web-seminar participants. It was 
furthermore argued that the experience with the gene product should be taken into account and as a 
consequence the requirements for the safety assessments could be reduced. If we assume i) no 
insertional effects and ii) all the secondary effects / cross-talk between metabolic pathways in different 
varieties of the same species to be comparable, then cisgenesis and traditional crossing could be 
considered equal. It is known (Filipecki and Malepszy, 2006), however, that insertional effects may 
occur and that there are differences in e.g. metabolic networks leading to natural toxins in different 
varieties within species. Furthermore, the copy number and position effects will likely make cisgenic 
plants different in most cases, as was also pointed out during the web-seminar: a higher copy number 
or a different position of the newly introduced gene in the plant genome may lead to increased 
expression, outside of levels as present in conventional varieties. 
 
Finally, both conventional breeding and any GM approach (cisgenesis, transgenesis, etc.) are followed 
by extensive breeding selection of parental lineage plants based on agronomic and phenotypic 
characterization (and compositional when appropriate). These recurrent (back) crosses could also 
eliminate any unwanted side effects of the breeding procedure, either GM or not, since the breeding 
selection is on the introduced trait. However, unintended side effects of any breeding procedure that 
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 are linked to the new trait, for instance as a result of secondary effects of the expressed product, but 
will not alter the phenotype of the plant, will not likely be detected in this way. 
5.5 Conclusions safety aspects 
From the considerations in this chapter it was concluded that the differences in safety aspects between 
cisgenic and transgenic GM plants may not be restricted solely to the type of insert. Hence, the 
cisgenic plants cannot be assessed on the basis of reduced data requirements only because of a 
relatively ‘safe’ choice of the inserted gene alone. Other factors like method of insertion, place of 
insertion and possible accompanying (unintended) changes in the genome and physiology of the 
recipient plant should be taken into account. The exact data requirements will have to be determined 
on a case-by-case basis, as is the case for transgenic GM crop varieties. 
 
At the same time it was concluded that the current distinction between ‘GMOs’ and ‘other new plant 
varieties’ does not lead to a balanced safety assessment for all novel plant varieties. New plant 
varieties form a continuum from conventional crosses in the field without any laboratory step via 
artificial mutagenesis using chemical treatment or radiation up to, for instance, transgenic plant 
varieties where whole metabolic routes from non-self sources have been introduced (or deleted). 
Cisgenic varieties are somewhere in the middle of this continuum. An optimal food and feed safety 
assessment should be based on the specific characteristics of the novel plant variety, rather than to the 
categorisation of the new plant products on the basis of one of the technologies used to obtain the new 
plant variety. 
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 6 Discussion and conclusions 
6.1 Discussion 
On the basis of the project results the following aspects have been identified and discussed: 
A With respect to the definition of cisgenesis it was discussed the following aspects are likely to cause 
a so-called ‘grey area’ when trying to define cisgenesis (or intragenesis):  
• The definition of species: it was concluded that there is no watertight definition of a species at this 
moment, as a result of the current discussions in plant taxonomy as well as a result of the different 
views on a biological species; 
• The (practical) crossability of crop plants: it is clear that a plant can be crossed when this can be 
achieved in the conventional way by means of sexual reproduction. In some cases this is not 
feasible and then different laboratory techniques may help to overcome difficulties of crossing in 
the field. This may result in a viable cross result (F1) in perhaps 50% of the cases and then we 
consider the lines still crossable, but what if a viable cross result (F1) is only obtained in 1% of the 
cases or 0.01%, or even less? In the end this will lead to a theoretical discussion on whether it is 
likely that the cross may ever result in a F1 line, as it will no longer be practical to test this in 
practice. The result will be a grey area with respect to the definition.  
• An extra definition problem may relate to the exchange of plastids: it is not clear whether this 
would fall under the definition of cis- or intragenesis and thus may create another part of the ‘grey 
area’. 
 
B Furthermore, there was general agreement that there should be a distinction between ’true’ 
cisgenesis, defined as a genetic modification of a recipient species with a natural gene from a 
crossable-sexually compatible- species, where the gene includes its exon/intron structure and its native 
promoter and terminator, and intragenesis, where the (order of) sequences are no longer fully ‘native’. 
It was concluded that cisgenesis and intragenesis can not be regarded as equivalent: small changes in 
coding sequences and/or regulatory elements may lead to extended changes in the plant’s physiology, 
and therefore should be assessed separately on a case-by-case basis with respect to potential toxicity 
and/or allergenicity. 
With respect to the safety assessment of cisgenic and intragenic plant varieties, it was determined that 
in the end only in the case of cisgenesis (assuming that the protein has a history of safe use (see 
discussions on definitions)) the cisgenic expressed protein may not have to be separately assessed, as it 
will feature in its ‘conventional’ make-up in the cisgenic plant variety. In the case of intragenic crosses 
the intragenic expressed protein is likely to be very similar to the conventional protein, but this will 
have to be assessed on a case-by-case basis as the level of expression and/or the characteristics of the 
expressed protein may have changed, depending on the composition and structure of the genetic 
construct. As a result, it was concluded that the introduced gene (and thereby the gene product) in the 
cisgenic approach, but not necessarily in the intragenic approach, is native and could for that reason be 
considered as safe. In this respect the assessment of cisgenic plant varieties can benefit from our 
knowledge of the plant gene and its expression product, and this aspect of the safety assessment can 
clearly be ‘light’ in the case of cisgenic varieties.  
 
C Both cis- and transgenesis make use of illegitimate recombination and deposit the T-DNA left 
border in the recipient plant, adjacent to the introduced gene. Therefore, it needs to be assessed in both 
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 cases whether there are any unintended effects because of the insertion (insertional mutagenesis). This 
aspect may become of less relevance in the near future, when exact positioning of the recombinant-
DNA construct may become increasingly feasible. It has been argued that in classical plant breeding 
many breeding techniques, e.g. chemical or irradiation mutagenesis, are used that probably resort often 
in more pronounced alterations of the genome than those that are likely to occur in the case of 
cisgenesis, but this is not a strong argument for cisgenesis being assessed as ‘traditional breeding’. 
Finally, in the case of intragenic as well as in transgenic GM approaches unintended secondary effects 
of the expression products of the introduced gene sequences may occur, which may lead to altered 
levels of proteins and/or secondary metabolites in the plant’s physiology that may require further 
toxicological and/or nutritional assessment. This is not likely to be the case in cisgenic varieties as the 
physiological ‘surroundings’ of the gene have not changed. At the same time it was concluded that this 
leads to the discrepancy that in the case of cisgenic varieties, the resulting plant will have to go 
through elaborate safety assessments whereas a very similar result of a conventional cross, with 
potential so-called linkage drag, will in general not be assessed for its food/feed safety. 
 
D The arguments brought forward by participating experts focused on the aspects mentioned under A 
en B. From the discussions it was clear that in any case it is not yet clear what characteristics the first 
marketed cisgenic plant varieties actually will have: e.g. whether they indeed will be cisgenic or rather 
intragenic according to the definitions as applied in this report, whether they will have significant 
changes in their composition and whether the newly introduced proteins have indeed a so-called 
‘history of safe use’. So far we can only make theoretic assessments of novel cisgenic plant varieties, 
as we lack (safety) data on such varieties. It may therefore be wise to gain expertise with these new 
developments: assess the derived products on a case-by-case basis, using the knowledge we have on 
our crop varieties. The safety assessment of cisgenic plant varieties is currently regulated within the 
European Union, and evaluation of the safety aspects of the different categories of novel cisgenic plant 
varieties will be performed when we have (more) data to assess for this goal. That will allow a better 
assessment of the actual differences between cisgenic and transgenic plant varieties, than just merely a 
theoretic assessment, as is only feasible at this moment in time. On the basis of ‘real’ data it can be 
assessed whether cisgenic plant varieties show fewer differences compared to conventional varieties 
than transgenic GM varieties. But even in that case it will be difficult to assess the cisgenic varieties as 
a different group as for specific aspects of the safety assessment (such as history of use of the 
expression products and potential insertional mutagenic effects of the genetic construct) the cisgenic 
varieties will have more in common with novel transgenic plant varieties than with conventional 
varieties. 
 
E Finally, it was discussed that currently new plant varieties form a continuum from conventional 
crosses in the field, without any human interference, to artificial mutagenesis resulting in arbitrary 
mutations, up to transgenic plant varieties which involves extensive DNA technology and, possibly, 
complex metabolic pathways that have been changed or newly introduced. Cisgenic crop varieties 
have been created with techniques involving genetic modification, although the resulting cisgenic GM 
crop might be closer to traditionally bred crops than to GMOs. Depending on the specific 
modifications and characteristics, cisgenic crop varieties will be somewhere in the middle of this 
continuum. From a scientific point of view, an optimal food and feed safety assessment for all new 
plant varieties should be based on the specific new characteristics of the individual novel plant variety, 
rather than on the categorisation of the new plant varieties and their derived products on the basis of 
(one of) the technologies used to obtain the new plant variety. 
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 6.2 Conclusions 
Existing knowledge on the newly expressed proteins in the cisgenic/intragenic plant varieties will, on 
a case-by-case basis, already be used within the current regulatory framework for the food and feed 
safety assessment of GM plant varieties. This thus may already lead to reduced requirements in 
specific aspects of the food and feed safety assessment. But, taking into account the specific features 
of cisgenic/intragenic plant varieties in comparison to conventional varieties on the one hand and 
transgenic GM varieties on the other hand, there is, from a food and feed safety perspective, no 
scientific basis for a general reduction of requirements for cisgenic crop plant varieties. 
 
This general conclusion is based on the following arguments:  
• There is general agreement that it is not possible to determine a watertight definition of cisgenic 
(or intragenic) plant varieties. 
 
• In the case of cisgenesis, including only cisgene products that are already part of the human or 
animal diet, the food and feed safety evaluation may be simplified with respect to the specific 
aspects related to the expression products, as indeed all these gene expression products have a 
‘history of safe use’, but not for other aspects in the safety assessment. This will already be part of 
the case-by-case approach in the current food and feed safety assessment of new GM plant 
varieties. For other types of cisgenic/intragenic crop varieties it was concluded that small changes 
in sequences and/or regulatory elements may lead to extended changes in the plant’s physiology, 
and therefore cisgenic/intragenic plant varieties should be assessed on a case-by-case basis with 
respect to their potentially toxicological / allergenic / nutritional characteristics. 
 
• Both cis- and transgenesis make use of illegitimate recombination and deposit the T-DNA left 
border in the donor plant, if the transformation is achieved via the use of the Agrobacterium 
tumefaciens transformation system. Therefore, in both cases risk assessment needs to assess 
whether the gene insertion has caused any unintended effects (insertional mutagenesis). The 
current risk assessment of GM plant varieties (including cisgenic varieties) largely focuses on any 
potential unintended effects of the genetic modification due to insertional effects (of the genetic 
construct, not just the T-DNA-fragment, and irrespective of the mode of transformation). This 
would thus apply to both novel cisgenic/intragenic as well as transgenic crop plant varieties.  
 
Finally, it was concluded that new plant varieties form a continuum from conventional crosses in the 
field, without any laboratory step being part of the breeding procedure (traditional breeding), up to 
transgenic plant varieties where recombinant-DNA techniques have been used to achieve major 
changes in the plant’s genome. On a biological level, the alterations can range from small changes 
(adding a single resistance gene) to extensive changes in which complex metabolic routes have been 
introduced. Depending on their specific modifications and characteristics, cisgenic crop varieties will 
be somewhere in the middle of this continuum. From a scientific point of view, an optimal food and 
feed safety assessment in the case of new plant varieties should be based on the specific new 
characteristics of the individual novel plant variety, rather than on the categorisation of the new plant 
varieties and their derived products on the basis of (one of) the technologies used to obtain the new 
plant variety. 
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